NIH funding uncertainty disrupts U.S. research, biotech investor sentiment

The NIH's budget allocation is under scrutiny amid funding uncertainty, which is hampering U.S. researchers and dampening biotech investor sentiment. The episode highlights concerns over federal research funding stability, though specific policy changes or data are not detailed. This matters because NIH funding is a key driver of biomedical innovation and biotech market confidence.